TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 1 | -3 | -9 | 13 | 23 | 5 |
| P | %wins | 100 | 100 | 0 | 0 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/23 16:06 | 5/21/23 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palantoni Frank | TX | D | M.d | 0 | 0.00 | 0 | 9 | 30 | 40 | D | |||||||||||||||
5/2/22 16:17 | 4/30/22 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palantoni Frank | TX | D | M.d | 0 | 0.00 | 0 | 4 | 15 | 31 | D | |||||||||||||||
4/27/21 16:49 | 4/24/21 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palantoni Frank | TX | D | M.d | 0 | 0.00 | 0 | 11 | 65 | 27 | D | |||||||||||||||
4/27/20 16:48 | 4/26/20 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palantoni Frank | TX | D | M.d | 0 | 0.00 | 0 | 3 | 27 | 16 | D | |||||||||||||||
5/23/06 11:09 | 5/19/06 | PBH | Prestige Brands Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Palantoni Frank | TX | DO | CEO,P | P | 25 | 10.39 | 4 | 2 | 8 | 33 | 0 | 1 | -3 | -9 | 13 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |